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Background: There are few data available about childhood tuberculosis (TB) in rural hospitals in low-income
countries. We assessed differences in epidemiological characteristics and treatment outcomes in children with TB
aged 0–4 versus 5–14 years in rural Ethiopia.
Methods: For this retrospective cross-sectional study, we analyzed childhood TB registers from a rural Ethiopian
hospital. We collected data on the number of cases, type of TB, and treatment outcomes using standard definitions.
By means of binary and logistic regression analyses, data were compared from 1998 to 2015 in children aged under
5 versus those aged 5–14 years.
Results: We included 1282 TB patients: 583 (45.5%) were under 5 years old, and 699 (54.5%) were aged 5–14 years.
More than half (67.2%, n = 862) had pulmonary TB (PTB), which was more common in younger children (82.5%,
481/583) than in older ones (54.5%, 381/699; p < 0.001). Most cases of PTB (87.5%, 754/862) were smear negative,
including virtually all (99.6%, 479/481) younger children and most older ones (72.2%, n = 275/381; p < 0.001). The
most common types of extrapulmonary TB (EPTB) were TB adenitis (54.5%, 229/420) and bone TB (20%, 84/420).
Children under five showed a lower prevalence of adenitis TB (9.9% [58/583] versus 24.5% [171/699], p < 0.001),
bone TB (2.9% [17/583] versus 9.6% [69/699], p < 0.001), and abdominal TB (0.9% [5/583] versus 6.3% [44/699], p <
0.001). Most diagnoses were new cases of TB (98.2%, 1259/1282). Overall, 63.5% (n = 814) of the children successfully
completed treatment (< 5 years: 56.6%, 330/583; 5–14 years: 69.2%, 489/699; p < 0.001). In total, 16.3% (n = 209)
transferred to another center (< 5 years: 19.4%, 113/583; 5–14 years: 13.7%, 96/699; p = 0.006). Thirteen percent of
patients (n = 167) were lost to follow-up (< 5 years: 16.0%, 93/583; 5–14 years: 10.4%, 74/699; p = 0.004). Fifty-two
(4.1%) children died (no age differences). Being aged 5–14 years was independently associated with successful
treatment outcomes (adjusted odds ratio 1.59; 95% confidence interval: 1.16, 1.94, p = 0.002).
Conclusions: We observed a very low diagnostic yield for spontaneous sputum smear in children with TB. In this
rural setting in Ethiopia, very young children tend to present with new cases of smear-negative PTB. They have less
EPTB than older children but more TB meningitis and show lower rates of treatment success.
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Tuberculosis (TB) remains an important challenge for glo-
bal health. The World Health Organization (WHO) esti-
mated that in 2017 there were about 10 million incident
cases of TB worldwide, and 10% of these were in children
under 15 years old [1]. This is probably an underestima-
tion, as childhood TB often remains undetected due to
diagnostic challenges [2, 3]. The burden of this disease in
children reflects its prevalence in adults [3].
Management of childhood TB poses challenges to
low- and middle-income countries. Morbidity and mor-
tality are high enough to make this one of the three pri-
mary infectious diseases related to poverty [4–6]. In
2017, about 233,000 children died from TB worldwide,
which translates to 13% of total deaths in children [1].
A 2018 WHO report ranked Ethiopia 14th worldwide
with regard to the global TB burden; 117,705 cases were
reported in 2017, with an estimated incidence rate of
164 cases per 100,000 population per year. Of the re-
ported cases in 2017, about 20,000 were in children
under 15 years [1].
Given the natural history of TB, age remains the most
important variable influencing the risk of disease progres-
sion following a primary infection with Mycobacterium tu-
berculosis. Disease manifestation patterns show clear
associations with age at the time of primary infection. Im-
mune-compromised children also carry an increased risk
for TB [6], so it seems prudent to categorize all children
under 2 years of age and immune-compromised children
of any age as being at high-risk for this disease [7].
Although several studies have been published about
childhood TB in Ethiopia, few have taken place in a rural
environment. Moreover, they do not generally compare
age groups in terms of epidemiology, disease manifesta-
tions, diagnosis or outcome [8–12], even though this in-
formation could be very useful for designing effective
treatment strategies.
Ethiopia’s National Tuberculosis and Leprosy Con-
trol Programme (NTLCP), launched in 1992, helped
standardize the registry of TB cases following WHO
guidelines [13, 14]. This study describes the main
characteristics of childhood TB in a rural hospital in
Southern Ethiopia over 18 years, according to NTLCP
registry data. We also compare epidemiological, clin-
ical and outcome data in children aged under 5 ver-
sus those aged 5 to 14 years.Methods
Study design, study site and period
This is a retrospective cross-sectional study from January
1998 to December 2015. We examined patient records in
children aged less than 15 years old and diagnosed with
TB at Gambo General Hospital, collecting data in linewith the NTLCP reporting guidelines and WHO stan-
dards [13, 14].
Gambo General Hospital is a private rural general hos-
pital with 135 beds. Since 2003, the hospital has had an
inpatient feeding center with around 15–20 beds for
treating severe acute malnutrition. It is 18 km from Arsi
Negele, the capital of West Arsi Province; 45 km from
Kuyera Hospital (the West Arsi reference hospital); and
250 km south of Addis Ababa. West Arsi Province has a
population of 1.9 million, and Gambo General Hospital
serves a population of about 95,000 people, living mostly
in a rural setting and subsisting from agriculture and
livestock.
In a study performed from July 2013 to June 2014 in
the Hetosa District of Oromia Region, Ethiopia, the inci-
dence of smear-positive pulmonary TB (PTB) was 214
(95% confidence interval [CI]: 163.3, 263.5)/ 100,000
persons per year [15]. A recent systematic review and
meta-analysis of HIV infection in tuberculosis patients
in Ethiopia from 2003 to 2017 showed that prevalence of
HIV in the country was 23.4% (95% CI 19.6, 27.2). In the
Oromia Region, where West Arsi is located, it was 20.9%
(95% CI 17.8, 24.0) [16].
Participants
Patients with a clinical suspicion of TB underwent a
diagnostic study before starting treatment. If symptoms
were consistent with PTB, patients provided three spu-
tum samples, usually from spontaneous sputum, al-
though gastric aspirates were taken in a few of the
younger children. Two positive smears indicated smear-
positive PTB. Patients with three negative smears re-
ceived treatment with antibiotics, and if the symptoms
continued, they were examined by chest X-ray. The fol-
lowing abnormalities on chest X-ray were suggestive of
TB :(1) enlarged hilar lymph nodes and opacification in
the lung tissue,(2) miliary mottling in lung tissue, and
(3) cavitation (common with older children) or pleural
or pericardial effusion. In case of respiratory symptoms,
patients with suggestive chest X-rays whose condition
did not improve with antibiotics were considered to have
smear-negative PTB. Miliary tuberculosis was classi-
fied as pulmonary TB because of the lesions in the
lungs [13, 14].
Extrapulmonary TB (EPTB) was generally diagnosed
clinically. The investigations used to diagnose the com-
mon forms of EPTB were: (1) for peripheral lymph
nodes, lymph node fine needle aspiration; (2) for TB
meningitis, lumbar puncture; (3) for pleural effusion,
chest X-ray plus pleural tap for biochemical analysis, cell
count and culture; (4) for abdominal TB, abdominal
ultrasound and ascites fluid analysis; (5) for osteoarticu-
lar TB, X-ray or joint tap, (6) for pericardial TB, ultra-
sound and pericardial tap. Tuberculous pleural effusion,
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considered EPTB [13, 14]. Children with EPTB were
screened for lung involvement by chest X-ray.
Patients with both PTB and EPTB were classified as
having PTB; these cases were not included in both cat-
egories. The only exception was TB meningitis: if pa-
tients diagnosed with TB meningitis by lumbar puncture
had an abnormal chest X-ray, they were considered as
having TB meningitis. Bacteriological confirmation by
culture was not undertaken. The Xpert MTB/RIF assay
had not yet been implemented during the study period.
A TB diagnosis resulted in three potential manage-
ment approaches: 1) hospital admission (seriously ill
PTB or EPTB patients), 2) registration and ambulatory
treatment at the TB clinic, or 3) transfer to the patient’s
local TB clinic.
Clinicians completed case notification forms for all
registered patients according to NTLCP reporting guide-
lines [13, 14], collecting data on: age, sex, weight, disease
status (new case, previously treated TB, return after loss
to follow-up, treatment failure), type of TB (smear-posi-
tive PTB, smear-negative PTB, EPTB), loss to follow-up,
treatment failure, death or transfer, HIV status, and
other clinico-epidemiological data. In this study, and in
line with the NTLCP, patients were considered to have
EPTB only in the absence of PTB. The registry does not
include household contact data. Patients who were cured
or completed treatment were categorized as having suc-
cessful treatment, while unfavorable outcomes were de-
fined as patients lost to follow-up, dying, those with
treatment failure, and transfers.
The treatment scheme changed during the period of
study, as shown in Additional file 1: Annex 1.
Statistical analysis
All collected data were double-checked for complete-
ness, entered into Excel, and exported to SPSS version
22.0 for analysis. We report variables of interest as fre-
quencies or means. We performed the chi-square test
and Fisher’s exact test to compare variables in univariate
analysis, expressing results as crude odds ratios (ORc)
with their 95% CIs. We then fit a logistic regression
model to identify predictors of treatment outcome based
on the adjusted odds ratio (ORa) and 95% CI. P values
of less than 0.05 were considered statistically significant.
Ethical approval
As the study was retrospective in nature, informed con-
sent was not required from patients’ parents or legal
guardians; however, all records were anonymized prior
to analysis. The approved Local Research and Publica-
tion Committee of the Gambo General Hospital and the
Health Unit and Ethical Review Committee of the Ethi-




From 1998 to 2015, 3534 patients were diagnosed with
TB, including 1282 (36.3%) children: 583 of them
(45.5%) were aged 0 to 4, and 699 (54.5%) were 5 to 14
years old. Figure 1 shows the distribution by age. Gender
distribution did not differ according to age groups. The
annual number of cases decreased over time, from more
than 260 cases in the first 2 years to 20 cases at the end
of the study (Fig. 2).
Epidemiological and clinical characteristics of children
under 5 versus children aged 5–14
Diagnostic results showed that PTB was the main type
of TB (67.2%), and it was more common in younger
children (82.5%) than in older ones (54.5%) (p < 0.001).
Most (87.5%) cases of PTB were smear negative; this re-
sult was more common in children under five (99.6%)
than in older ones (72.2%; p < 0.001) (Table 1).
TB adenitis was the most common type of EPTB
(54.5%), followed by bone TB (20%), abdominal TB
(11.7%) and TB meningitis (6.2%). Children under five
showed a lower prevalence of adenitis TB (9.9% [58/583]
versus 24.5% [171/699], p < 0.001), bone TB (2.9% [17/
583] versus 9.6% [69/699], p < 0.001) and abdominal TB
(0.9% [5/583] versus 6.3% [44/699], p < 0.001). TB men-
ingitis was slightly more common in the younger age
group (2.6% versus 1.6%).
Most patients were registered with new cases of TB,
especially younger children (99.3% versus 97.3%; p <
0.006). Indeed, no TB cases in the under-five group
showed failure or previous treatment, compared to eight
and five cases, respectively, in older children (p = 0.009
and p = 0.041, respectively).
HIV status was tested in 31.2% of the children (33.2%
of children under 5, and 44.4% of children aged 5–14;
p = 0.003). Only 2.3% of the patients tested had a posi-
tive result. Determination of HIV status increased dra-
matically following implementation of the NTLCP in
2005 (5.2% before 2005, 99.4% afterwards).
Of 1282 total children, 510 (39.8%) were admitted,
with a predominance of young children among those
hospitalized (p < 0.001) (Table 1).
Treatment outcome
Treatment outcomes were: 814 (63.5%) had successful
treatment (56.6% in children < 5 years and 69.2% in chil-
dren aged 5–14; p < 0.001); 209 (16.3%) transferred to
another center (19.4% versus 13.7%; p = 0.006); 167
(13%) were lost to follow-up (16.0% versus 10.4%; p =
0.004); and 52 (4.1%) died (4.1% versus 4.0%; p = 0.999;
Fig. 1 Number of children with tuberculosis, by age
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over time in childhood TB; these were quite variable.
Table 3 summarizes treatment outcome predictors in
children with TB. In multivariable logistic regression, the
only variable independently associated with successful
treatment outcomes was being aged 5–14 years (ORa
1.59; 95% CI: 1.16, 1.94, p = 0.002).
Discussion
More than a third (36.3%) of the total recorded cases of
TB in our study population occurred in children—a higher
proportion than reported elsewhere in Ethiopia [9, 11, 17],
in the national estimate (16.1%) [18], and in other areas of
sub-Saharan Africa [19]. Several factors may have contrib-
uted to these results. As our study took place in a private
hospital, it offered several services, such as X-ray diagnosis
and cheaper treatment, that may not have been present inFig. 2 Tuberculosis cases in children total, aged 0–4 years, and 5–14 years,public facilities. At the same time, the hospital has a refer-
ral malnutrition clinic, where children with malnutrition
are admitted for a minimum fee, and these children may
have TB. Some overdiagnosis of child TB cases may have
also been possible.
Given the scant data available on childhood TB (and
the dominance of high-income settings where studies
exist), in 2007 WHO called for additional research to
characterize the global epidemiology of the disease [20].
Nearly half (45.5%) of the total childhood TB cases
were in children under five, which is consistent with re-
sults from a previous study in Tanzania [21] but higher
than in other studies in Ethiopia and other low- and
middle-income countries, where the proportion of TB
cases in this group is estimated at 11 to 23% [8, 9, 22].
Overall, the heterogeneous estimates reflect limitations
in available data both at a country and regional level.1998 to 2015
Table 1 Epidemiological and clinical characteristics in children with tuberculosis: children aged 0–4 years versus 5–14 years
Total (N = 1282) n (%) 0–4 years (N = 583) n (%) 5–14 years (N = 699) n (%) Crude odds ratio (95% CI) P value
Sex
Boys 674 (52.6) 319 (54.7) 355 (50.8) 1
Girls 608 (47.4) 264 (45.3) 344 (49.2) 0.85 (0.69, 1.06) 0.126
TB category
Pulmonary TB 862 (67.2) 481 (82.5) 381 (54.5) 3.93 (3.03, 5.10) < 0.001
Extrapulmonary TB 420 (32.8) 102 (17.5) 318 (45.8) 1
Type of pulmonary TB (N = 862)
Smear positive 108 (12.5) 2 (0.4) 106 (27.8) 1
Smear negative 692 (80.3) 437 (90.8) 275 (66.9) 0.01 (0.00, 0.04) < 0.001
Smear missing 62 (7.2) 42 (8.7) 20 (5.3) –
Type of extrapulmonary TB
Adenitis TB 229 (17.9) 58 (9.9) 171 (24.5) 0.34 (0.24, 0.48) < 0.001
Bone TB 84 (6.6) 17 (2.9) 67 (9.6) 0.28 (0.16, 0.48) < 0.001
Abdominal TB 49 (3.8) 5 (0.9) 44 (6.3) 0.12 (0.05, 0.32) < 0.001
TB meningitis 26 (2.0) 15 (2.6) 11 (1.6) 1.65 (0.75, 3.62) 0.205
Other and unclassified 32 (2.5) 7 (1.2) 25 (3.6) 0.32 (0.13, 0.75) 0.01
Category of TB
New 1259 (98.2) 579 (99.3) 680 (97.3) 4.04 (1.37, 11.95) 0.006
Transfer 10 (0.6) 4 (0.7) 6 (0.9) 0.79 (0.22, 2.84) 0.763
Failure 8 (0.6) 0 (0.0) 8 (1.1) NA 0.009
Relapse 5 (0.4) 0 (0.0) 5 (0.7) NA 0.041
HIV status
Known 400 (31.2) 157 (33.2) 237 (44.4) 1
Unknown 882 (68.8) 426 (66.8) 457 (35.6) 0.69 (0.54, 0.87) 0.003
HIV status results (N = 400)
Negative 391 (97.8) 154 (98.1) 237 (97.5) 1
Positive 9 (2.3) 3 (1.9) (2.5) 0.76 (1.19, 3.12) 0.999
Hospital admission
No 772 (67.1) 303 (52.0) 469 (67.1) 1
Yes 510 (39.8) 280 (48.0) 230 (32.9) 1.88 (1.50, 2.36) < 0.001
CI confidence interval, HIV human immunodeficiency virus
Table 2 Treatment outcomes in children with tuberculosis: children aged 0–4 years versus 5–14 years
Total (N = 1282) n (%) 0–4 years (N = 583) n (%) 5–14 years (N = 699) n (%) Crude odds ratio (95% CI) P value
Success 814 (63.5) 330 (56.6) 484 (69.2) 0.58 (0.46, 0.73) < 0.001
Transfer 209 (16.3) 113 (19.4) 96 (13.7) 1.51 (1.12, 2.03) 0.006
Loss to follow-up 167 (13.0) 93 (16.0) 74 (10.6) 1.60 (1.15, 2.22) 0.004
Death 52 (4.1) 24 (4.1) 28 (4.0) 1.03 (0.59, 1.79) 0.999
Failure 3 (0.2) 1 (0.2) 2 (0.3) 0.60 (0.05, 6.62) 0.999
Missing data 37 (2.9) 22 (3.8) 15 (2.1) – –
CI confidence interval
Ramos et al. BMC Public Health          (2019) 19:856 Page 5 of 9
Fig. 3 Percentage of treatment success rates in childhood tuberculosis, 1998 to 2015. Values of percentage of treatment success in total cases of
childhood tuberculosis
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its burden provides a good proxy measure for TB preva-
lence in the community [19]. Therefore, the high rates
of childhood TB that we observed suggest that the com-
munity bears a high burden of untreated disease.Table 3 Predictors of treatment outcome of childhood tuberculosis
Characteristics Treatment outcome
Successful No (%) Unfavorable No (%)
Sex
Boys 418 (51.4) 256 (54.7)
Girls 396 (48.6) 212 (45.3)
Age group
Under 5 330 (40.5) 243 (54.1)
5–14 years 485 (59.5) 215 (45.9)
Type of TB
PTBSP 80 (9.8) 28 (6.0)
PTBSN 445 (54.7) 309 (66.0)
EPTB 289 (35.5) 131 (28.0)
New TB
No 16 (2.0) 7 (1.5)
Yes 798 (98.0) 461 (98.5)
HIV status
Negative 249 (30.6) 142 (30.3)
Positive 7 (0.9) 2 (0.4)
Unknown 558 (68.6) 324 (69.2)
PTBSP pulmonary tuberculosis smear positive, PTBSN pulmonary tuberculosis smear
virus, ORc crude odds ratio, ORa adjusted odds ratioMoreover, 41.6% of Ethiopia’s population is aged under
15 years [23], and this is also relevant to the burden.
There has been a decrease in prevalence of tubercu-
losis in Ethiopia over the past 15 years [1]. In our study,
the annual case count also decreased over the study(TB)
Univariate analysis Multivariate analysis
ORc (95% CI) P value ORa (95% CI) P value
Ref. Ref.
0.87 (0.69, 1.09) 0.248 0.89 (0.70, 1.12) 0.327
Ref. Ref.
1.72 (1.37, 2.17) < 0.001 1.52 (1.16, 1.94) 0.002
Ref. Ref.
1.98 (1.26, 3.12) 0.003 1.51 (0.93, 2.47) 0.092
1.29 (0.80, 2.08) 0.288 1.15 (0.71, 1.88) 0.553
Ref. Ref.
0.75 (0.30, 1,95) 0.542 0.98 (0.39, 2.54) 0.990
Ref. Ref.
1.01 (0.79, 1.30) 0.887 0.98 (0.76, 1.27) 0.926
0.50 (0.10, 2.44) 0.393 0.50 (0.10, 2.48) 0.386
-negative, EPTB extrapulmonary tuberculosis, HIV human immunodeficiency
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patients transferred to local health centers (and whose
cases were therefore registered there instead of in the
hospital) increased as these centers were newly con-
structed in the area. We consider that most of the re-
duction in numbers is due to a shift in patients receiving
treatment in new community centers rather than in the
hospital.
Most cases (98.2%) were new TB rather than previ-
ously treated TB. This proportion was slightly higher
than in other studies of childhood TB (92%) [8, 9]. The
younger age group presented with more new cases,
which is logical, as for the most part such children are
too young to have already been treated for the disease.
In general, previously treated TB and transfer cases in
our study were infrequent.
PTB was the most common type of TB in our chil-
dren, which is consistent with the literature [18]. In our
study, microbiological diagnosis (only acid-fast bacillus
smear positivity, as bacteriological confirmation by cul-
ture was not done) was very low, as in other studies in
Africa [21]. Just 12.5% of the PTB cases were smear
positive, which is also in line with previous reports in
Ethiopia [9, 11]. Most of the patients with smear-
positive PTB were aged 5–14 years. Children develop
mainly primary PTB presenting with lymph nodes and
areas of parenchymal infiltration, and they tend to have
low bacillary load and immunological changes, which ex-
plains this result [9]. Moreover, young children rarely
produce sputum samples for smear microscopy, so they
are generally diagnosed based on clinical examination
and chest X-ray [24]. This was also true in our study, in
line with NTLCP/WHO guidelines on diagnosing chil-
dren [9]. The probability of smear positive sputum is
positively correlated with the child’s age [8, 9, 24, 25].
Using other sample types, such as gastric aspirate,
results in a higher diagnostic yield than spontaneous
sputum in children. The Xpert MTB/RIF assay in
sputum and gastric aspirates may identify M. tubercu-
losis in a greater percentage of cases in this group
[25–27]. Thus, the gradual introduction of Xpert
MTB/RIF in gastric aspirate and induced sputum
samples could help to improve diagnosis in children
under 15 in rural settings [26, 27].
EPTB made up a third of the childhood TB cases,
which is a lower proportion than in the studies by Hailu
et al. [9] and Tilahun and Gebre-Selassie [8], where
EPTB accounted for about half. There were more cases
of EPTB in the older age group compared to the youn-
ger children (45.8% versus 17.5%), which is consistent
with Hailu et al’s [9] results in Ethiopia and Mtabho et
al’s [22] observations in Tanzania. In these studies, as in
ours, a patient with both PTB and EPTB was classified
as having PTB.On the other hand, there was a slightly higher propor-
tion of TB meningitis in children under five (2.6% versus
1.6% of total TB); it is well known that this type of TB is
more frequent in children under three [27].
Abdominal TB appeared less frequently in younger
children (4.9%) compared to older ones (13.8%). Al-
though this variant is rare in children, most reported
cases are in low- and middle-income countries with a
considerable TB burden. Consistent with our results,
most cases of abdominal TB are in patients aged over
five [28, 29]. Diagnosis is extremely challenging; our pa-
tients were diagnosed by abdominal ultrasound, ascitic
fluid analysis (lymphocytosis) and clinical suggestion be-
cause microbiological confirmation was not possible.
Only a few cases had histopathological diagnosis.
Overall TB/HIV co-infection in our series showed a
prevalence of 2.3%, much lower than elsewhere in
Ethiopia, where it ranges from 10 to 28.2% [8, 9, 30–34];
in other African countries, where it ranges from 14 to
50% [19, 31, 33]; and in Southeast Asia [22, 35]. The low
proportion of our patients tested for HIV precludes any
conclusion on why the prevalence was so low; however,
we can cautiously speculate that it is because HIV is less
prevalent in rural populations than in other areas of
Ethiopia [36, 37].
In our study, 39.8% of the children were admitted to
hospital. Some patients were hospitalized for reasons
other than TB, such as severe acute malnutrition, and
were only then diagnosed with TB. Hospitalization was
more frequent in the under-five group.
TB programs in sub-Saharan Africa rarely assess treat-
ment outcomes in children [18]. The WHO considers an
overall treatment success rate of 85% to indicate good
quality TB case management [38]. Our success rate—
63.5%—was low compared to that achieved elsewhere in
Ethiopia (~ 85%) [8, 9, 11] and Africa [22]. If we assume
that the patients transferred to other TB clinics (16.3%)
fully completed the course of treatment, though, the
success rate of 80% is closer to the WHO target [38].
Indeed, the transfer rate was relatively high in our
series [8, 9, 11] because patients beginning treatment
during hospitalization in Gambo General are registered
in their local health center upon discharge, and they
complete therapy there [39]. Due to limitations in these
registry data, we could not determine the final treatment
outcome in these patients [39].
In our series, the proportion of patients who suc-
cessfully completed treatment was lower in children
under 5 than in those aged 5–14 (56.6% versus
69.2%), but the transfer rate was higher (19.4% versus
13.7%). The rate of treatment loss to follow-up was
13%—higher than in other studies in Ethiopia with
more urban and periurban settings [8, 9] and in
Tanzania [21]. However, our loss to follow-up rate
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jumo et al. [19] in Nigeria.
With regard to the mortality rate, the 4.1% we ob-
served is within the range reported in other studies of
childhood TB in Ethiopia [8, 9, 11, 33]. Elsewhere in Af-
rica, mortality has higher: 10.5% in Botswana [40], 10.6%
in Tanzania [21] and 17% in Malawi [41].
Young children, particularly those under two years of
age, are at higher risk of dying from TB because their
immune system is still immature [9, 17, 27, 42]. We did
not see a difference in fatal outcomes in our series based
on age, although this result may be confounded by the
lack of treatment outcome data for transfer patients.
In terms of treatment outcome predictors, age group
was the only variable that was independently associated
with treatment success. This outcome was significantly
higher in 5–14-year-olds compared to the under-5 group.
Other studies have reported similar findings [8, 9, 18, 43].
In contrast, other series have reported significant asso-
ciations between treatment failure and HIV co-infection,
unknown serostatus and malnutrition [2, 9, 39, 44].
The findings of this study must be interpreted in light
of its limitations. First, it is common to find both PTB
and EPTB in the same pediatric patient, but in this study
the variable was dichotomized (EPTB only in the ab-
sence of PTB), following WHO definitions. In children,
this classification can obscure very important informa-
tion about serious cases of TB, for instance if the child is
diagnosed as having PTB but also has TB meningitis,
which could be much more life threatening. Secondly,
we were unable to collect sociological data and only lim-
ited data about HIV infection, which might have affected
the risk of a poor outcome. Finally, Gambo General
Hospital is a private hospital, and patients were often re-
ferred from other health facilities for diagnosis and ad-
mission but then transferred to their local health center
following the intensive treatment phase. Thus, we might
have underestimated treatment failure and mortality
rates. Additional limitations are the retrospective and
hospital-based nature of the study, which could cause
bias. Moreover, there also seem to be recent changes in
health system in the area, which could depress estimates
of prevalence.
Conclusions
Data collection on childhood TB in rural health facilities
is important for understanding the epidemiology of this
disease. Because spontaneous sputum smear has a very
low diagnostic yield in children in low- and middle-
income countries (and particularly in children under
five), alternative diagnostic methods, such as Xpert
MTB/RIF in gastric aspirates, become more important.
In this rural setting in Ethiopia, children under five usu-
ally present with new smear-negative PTB. They haveless EPTB than children aged 5 to 14 but more TB men-
ingitis. Younger children are admitted more frequently
and show lower rates of successful treatment.
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